Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions.
Mol Ther Oncolytics
; 30: 132-149, 2023 Sep 21.
Article
in En
| MEDLINE
| ID: mdl-37654973
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos